A longitudinal study on IL-2, sIL-2R, IL-4 and IFN-γ in multiple sclerosis CSF and serum (Q67899471)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1827837 AND SRC:MED&resulttype=core&format=json

19 September 2019

title

A longitudinal study on IL-2, sIL-2R, IL-4 and IFN-gamma in multiple sclerosis CSF and serum (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1827837 AND SRC:MED&resulttype=core&format=json

19 September 2019

A longitudinal study on IL-2, sIL-2R, IL-4 and IFN-γ in multiple sclerosis CSF and serum (English)

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90050-H

4 December 2022

1 reference

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90050-H

4 December 2022

author name string

P. Gallo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1827837

4 December 2022

M. G. Piccinno

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1827837

4 December 2022

B. Tavolato

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1827837

4 December 2022

A. Sidén

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1827837

4 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1827837

4 December 2022

publication date

1 February 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1827837 AND SRC:MED&resulttype=core&format=json

full work available at URL

19 September 2019

https://api.elsevier.com/content/article/PII:0022510X9190050H?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90050-H

https://api.elsevier.com/content/article/PII:0022510X9190050H?httpAccept=text/plain

4 December 2022

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90050-H

Journal of the Neurological Sciences

4 December 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1827837 AND SRC:MED&resulttype=core&format=json

19 September 2019

volume

101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1827837 AND SRC:MED&resulttype=core&format=json

19 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1827837 AND SRC:MED&resulttype=core&format=json

19 September 2019

page(s)

227-232

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1827837 AND SRC:MED&resulttype=core&format=json

Interleukin-2 receptor levels indicating relapse in multiple sclerosis

19 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90050-H

Differential growth requirements and effector functions of alpha/beta and gamma/delta human T cells

4 December 2022

2

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90050-H

A functional dichotomy in CD4 T lymphocytes

4 December 2022

3

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90050-H

MS: a localized immune disease of the central nervous system

4 December 2022

4

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90050-H

Lymphokine-mediated regulation of the proliferative response of clones of T helper 1 and T helper 2 cells

4 December 2022

6

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90050-H

Detection of IgG oligoclonal bands in unconcentrated CSF by means of agarose isoelectric focusing, double immunofixation peroxidase staining and avidin-biotin amplification

4 December 2022

7

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90050-H

Interleukin-2 levels in serum and cerebrospinal fluid of multiple sclerosis patients

4 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90050-H

Immune activation in multiple sclerosis: study of IL-2, sIL-2R, and gamma-IFN levels in serum and cerebrospinal fluid

4 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90050-H

MS: a CNS and systemic autoimmune disease

4 December 2022

13

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90050-H

In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis

4 December 2022

14

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90050-H

The role of interleukin 2 in autoimmunity

4 December 2022

15

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90050-H

FURTHER NOTES ON DISABILITY EVALUATION IN MULTIPLE SCLEROSIS, WITH SCALE MODIFICATIONS

4 December 2022

16

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90050-H

Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. Analysis with anti-2H4 monoclonal antibody

4 December 2022

17

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90050-H

Two types of mouse helper T-cell clone Implications for immune regulation

4 December 2022

18

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90050-H

Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities

4 December 2022

20

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90050-H

Criteria for the clinical diagnosis of multiple sclerosis

4 December 2022

22

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90050-H

PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS

4 December 2022

24

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90050-H

A susceptibility locus for multiple sclerosis is linked to the T cell receptor beta chain complex

4 December 2022

25

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90050-H

The role of IL4 and IL5: characterization of a distinct helper T cell subset that makes IL4 and IL5 (Th2) and requires priming before induction of lymphokine secretion

4 December 2022

28

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90050-H

Elevated serum interleukin-2 levels in chronic progressive multiple sclerosis

4 December 2022

30

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90050-H

Correlation of immunological studies and disease progression in chronic progressive multiple sclerosis

4 December 2022

31

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90050-H

Serial studies of serum interleukin-2 in chronic progressive multiple sclerosis patients: occurrence of 'bursts' and effect of cyclosporine

4 December 2022

32

1 reference

https://api.crossref.org/works/10.1016/0022-510X(91)90050-H

4 December 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1827837 AND SRC:MED&resulttype=core&format=json

19 September 2019

1 reference